Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1490 (LINC01490) is a member of the long intergenic non-coding RNA (lincRNA) class, which consists of autonomously transcribed non-protein-coding RNAs longer than 200 nucleotides that do not overlap protein-coding regions[1][3][5][9]. LincRNAs, in general, may function in *chromatin remodeling, regulation of gene transcription, RNA stabilization, and the modulation of genome architecture*, frequently with tissue- and context-specific effects[5][7][9]. Thousands of lincRNAs have been annotated, but only a minor fraction have been functionally characterized; no function or disease association is currently annotated for LINC01490 specifically in major gene or literature databases[1][3][5][9]. It is not considered a classic druggable therapeutic target (such as a receptor, enzyme, or transporter), and there are no known interacting drugs, mechanisms of drug action, or biomarker indications for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1490 (LINC01490).